TGIF It’s been a wild week on this blog with many thoughts going out to the future of stem cells in Texas. What about stem cell headlines of the week? Some wildness there too and lots of discussion of translational applications, which is exciting. This week let’s start in reverse order with the ugly and […]
TGIF: good, bad, ugly stem cell headlines of week of May 25 Read More »
If you ever had a really bad day, March 13, 2012 might have been just such a bad day for one Dr. Steven Victor, aka “Dr LookGood”, because he received an official warning letter from the FDA. Why? Dr. Victor, who reportedly greets each patient with the catch phrase “You look so much more beautiful than your picture”, is
Dr Lookgood, dermatologist to the stars, gets FDA warning letter Read More »
They say politics makes strange bedfellows….remember the Witherspoon Council? These are the fellows who are the BFFs of the two scientists suing to stop federal funding of human embryonic stem cell (hESC) research. They also wrote a large, very stodgy tome about stem cell research, in which they mentioned me and this blog…kinda implying we
Witherspoon Council, Komen, and Fox News Read More »
Yesterday Geron announced it would be immediately stopping its stem cell research program. What does this mean? While this program has (or should I say “had”) a number of elements, at its heart was of course its hESC-based OPC drug (GRNOPC1) for spinal cord injury, which was in an FDA-approved Phase I Clinical Trial that
The day after Geron news: a realistic outlook for the stem cell field Read More »
Why does it worry me that the Vatican is having a stem cell conference? One of the hallmarks of Democracy is separation of church and state. When states mix religion into politics and government, the results have during human history been disastrous. Equally dismal has been the relationship between religion and science. Ever since the
The Vatican Stem Cell Meeting…is mixing religion and science a good idea? Read More »
There are many stories in the news about stem cells right now. Some of the stories are positive and some are negative in terms of the actual news. A separate issue is that some of the stories do a good job, while others are very inaccurate or use the news to confuse and push their
Stem cells in the media today: the good and the ugly Read More »
As much as so many were excited yesterday about the enrollment of the first patient in a CIRM-funded clinical trial, I did not see a mention of a very important element. The patient. Our excitement about the clinical trial moving forward is understandable, but we also need to keep a sober perspective on the fact
The news of CIRM and clinical trial: don’t forget the patient Read More »
Remember the Lung Institute? Many patients raised red flags about their experiences there. It was also once known as the Lung Health Institute. More generally, patients who have been harmed by stem cell clinics have had to rely on other ways beyond the FDA to try to do something about it. The FDA has been
Lung Institute stem cell clinic loses class action suit, patients awarded $9M Read More »
One of the most contentious areas in the regenerative medicine arena is whether a fat tissue product called stromal vascular fraction or SVF is a drug. The FDA says SVF, even in autologous form, is a drug. It is seeking an injunction against a California-based network of SVF clinics but lost the initial case. That
Recommend reads: FDA SVF warning, big Aspen grant, CSI finale invokes stem cells Read More »
My lab is focused in part on chromatin states in stem cells and cancer including heterochromatin. In fact, my lab’s website is chromatin.com. Heterochromatin is dense, often inactive chromatin. By H&E staining and electron microscopy, heterochromatin looks dark compared to the rest of the nucleus, largely composed of euchromatin. Toward the end of my postdoc
Weekly reads: heterochromatin, H3.3, Mesoblast bump Read More »